VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
357
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
71
Interactions with Platform & by Email
PARTICIPANTS
14
Unique # Participated
VALIDATIONS
6
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
150
PAGES
221
EDITION
9
PRICE
USD $4950
It Pays to Understand the Dynamics of Competition in Your Business Ecosystem.
Who Are Your Competitors in the Leukapheresis Market?
Amid the COVID-19 crisis, the global market for Leukapheresis estimated at US$21.2 Million in the year 2020, is projected to reach a revised size of US$31.9 Million by 2027, growing at aCAGR of 6% over the period 2020-2027. Leukapheresis Devices, one of the segments analyzed in the report, is projected to record 6.2% CAGR and reach US$14.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Leukapheresis Disposables segment is readjusted to a revised 5.9% CAGR for the next 7-year period.
The Leukapheresis market in the U.S. is estimated at US$6.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.6 Million by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.We bring years of research experience to this 9th edition of our report. The 221-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Allcells LLC; Asahi Kasei Medical Co., Ltd.; BioIVT; Caltag Medsystems Limited; Fresenius SE & Co. KGaA; Haemonetics Corporation; HemaCare Corporation; Key Biologics, LLC.; MacoPharma SA; Ppa Research Group, Inc.; Precision Medicine Group, Inc.; StemCell Technologies Inc.; StemExpress; Terumo BCT, Inc.; Zenbio, Inc.
» Application (Research, Therapeutic) » End-Use (Blood Component Providers & Blood Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Transfusion Centers) » Product (Leukapheresis Devices, Leukapheresis Disposables)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Leukapheresis Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Leukapheresis Global Market Estimates and Forecasts in US$ by Region/Country: 2020-2027 |
| Leukapheresis Global Retrospective Market Scenario in US$ by Region/Country: 2012-2019 |
| Leukapheresis Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| Leukapheresis Devices (Product) World Market by Region/Country in US$: 2020 to 2027 |
| Leukapheresis Devices (Product) Historic Market Analysis by Region/Country in US$: 2012 to 2019 |
| Leukapheresis Devices (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Leukapheresis Disposables (Product) Potential Growth Markets Worldwide in US$: 2020 to 2027 |
| Leukapheresis Disposables (Product) Historic Market Perspective by Region/Country in US$: 2012 to 2019 |
| Leukapheresis Disposables (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Research (Application) Global Market Estimates & Forecasts in US$ by Region/Country: 2020-2027 |
| Research (Application) Retrospective Demand Analysis in US$ by Region/Country: 2012-2019 |
| Research (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Therapeutic (Application) Demand Potential Worldwide in US$ by Region/Country: 2020-2027 |
| Therapeutic (Application) Historic Sales Analysis in US$ by Region/Country: 2012-2019 |
| Therapeutic (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 |
| Blood Component Providers & Blood Centers (End-Use) Worldwide Latent Demand Forecasts in US$ by Region/Country: 2020-2027 |
| Blood Component Providers & Blood Centers (End-Use) Global Historic Analysis in US$ by Region/Country: 2012-2019 |
| Blood Component Providers & Blood Centers (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Academic & Research Institutes (End-Use) Sales Estimates and Forecasts in US$ by Region/Country for the Years 2020 through 2027 |
| Academic & Research Institutes (End-Use) Analysis of Historic Sales in US$ by Region/Country for the Years 2012 to 2019 |
| Academic & Research Institutes (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Global Opportunity Assessment in US$ by Region/Country: 2020-2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Historic Sales Analysis in US$ by Region/Country: 2012-2019 |
| Pharmaceutical & Biotechnology Companies (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Hospitals & Transfusion Centers (End-Use) Worldwide Sales in US$ by Region/Country: 2020-2027 |
| Hospitals & Transfusion Centers (End-Use) Historic Demand Patterns in US$ by Region/Country: 2012-2019 |
| Hospitals & Transfusion Centers (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Leukapheresis Market Share (in %) by Company: 2019 & 2025 |
| United States Leukapheresis Market Estimates and Projections in US$ by Product: 2020 to 2027 |
| Leukapheresis Market in the United States by Product: A Historic Review in US$ for 2012-2019 |
| United States Leukapheresis Market Share Breakdown by Product: 2012 VS 2020 VS 2027 |
| United States Leukapheresis Latent Demand Forecasts in US$ by Application: 2020 to 2027 |
| Leukapheresis Historic Demand Patterns in the United States by Application in US$ for 2012-2019 |
| Leukapheresis Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 |
| United States Leukapheresis Latent Demand Forecasts in US$ by End-Use: 2020 to 2027 |
| Leukapheresis Historic Demand Patterns in the United States by End-Use in US$ for 2012-2019 |
| Leukapheresis Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027 |
| CANADA |
| Canadian Leukapheresis Market Estimates and Forecasts in US$ by Product: 2020 to 2027 |
| Canadian Leukapheresis Historic Market Review by Product in US$: 2012-2019 |
| Leukapheresis Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027 |
| Canadian Leukapheresis Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027 |
| Leukapheresis Market in Canada: Summarization of Historic Demand Patterns in US$ by Application for 2012-2019 |
| Canadian Leukapheresis Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Canadian Leukapheresis Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027 |
| Leukapheresis Market in Canada: Summarization of Historic Demand Patterns in US$ by End-Use for 2012-2019 |
| Canadian Leukapheresis Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| JAPAN |
| Japanese Market for Leukapheresis: Annual Sales Estimates and Projections in US$ by Product for the Period 2020-2027 |
| Leukapheresis Market in Japan: Historic Sales Analysis in US$ by Product for the Period 2012-2019 |
| Japanese Leukapheresis Market Share Analysis by Product: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Leukapheresis in US$ by Application: 2020 to 2027 |
| Japanese Leukapheresis Market in US$ by Application: 2012-2019 |
| Leukapheresis Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Leukapheresis in US$ by End-Use: 2020 to 2027 |
| Japanese Leukapheresis Market in US$ by End-Use: 2012-2019 |
| Leukapheresis Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 |
| CHINA |
| Chinese Leukapheresis Market Growth Prospects in US$ by Product for the Period 2020-2027 |
| Leukapheresis Historic Market Analysis in China in US$ by Product: 2012-2019 |
| Chinese Leukapheresis Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Demand for Leukapheresis in US$ by Application: 2020 to 2027 |
| Leukapheresis Market Review in China in US$ by Application: 2012-2019 |
| Chinese Leukapheresis Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| Chinese Demand for Leukapheresis in US$ by End-Use: 2020 to 2027 |
| Leukapheresis Market Review in China in US$ by End-Use: 2012-2019 |
| Chinese Leukapheresis Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European Leukapheresis Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Leukapheresis Market Demand Scenario in US$ by Region/Country: 2020-2027 |
| Leukapheresis Market in Europe: A Historic Market Perspective in US$ by Region/Country for the Period 2012-2019 |
| European Leukapheresis Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Leukapheresis Market Estimates and Forecasts in US$ by Product: 2020-2027 |
| Leukapheresis Market in Europe in US$ by Product: A Historic Review for the Period 2012-2019 |
| European Leukapheresis Market Share Breakdown by Product: 2012 VS 2020 VS 2027 |
| European Leukapheresis Addressable Market Opportunity in US$ by Application: 2020-2027 |
| Leukapheresis Market in Europe: Summarization of Historic Demand in US$ by Application for the Period 2012-2019 |
| European Leukapheresis Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| European Leukapheresis Addressable Market Opportunity in US$ by End-Use: 2020-2027 |
| Leukapheresis Market in Europe: Summarization of Historic Demand in US$ by End-Use for the Period 2012-2019 |
| European Leukapheresis Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| FRANCE |
| Leukapheresis Market in France by Product: Estimates and Projections in US$ for the Period 2020-2027 |
| French Leukapheresis Historic Market Scenario in US$ by Product: 2012-2019 |
| French Leukapheresis Market Share Analysis by Product: 2012 VS 2020 VS 2027 |
| Leukapheresis Quantitative Demand Analysis in France in US$ by Application: 2020-2027 |
| French Leukapheresis Historic Market Review in US$ by Application: 2012-2019 |
| French Leukapheresis Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Leukapheresis Quantitative Demand Analysis in France in US$ by End-Use: 2020-2027 |
| French Leukapheresis Historic Market Review in US$ by End-Use: 2012-2019 |
| French Leukapheresis Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| GERMANY |
| Leukapheresis Market in Germany: Recent Past, Current and Future Analysis in US$ by Product for the Period 2020-2027 |
| German Leukapheresis Historic Market Analysis in US$ by Product: 2012-2019 |
| German Leukapheresis Market Share Breakdown by Product: 2012 VS 2020 VS 2027 |
| Leukapheresis Market in Germany: Annual Sales Estimates and Forecasts in US$ by Application for the Period 2020-2027 |
| German Leukapheresis Market in Retrospect in US$ by Application: 2012-2019 |
| Leukapheresis Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 |
| Leukapheresis Market in Germany: Annual Sales Estimates and Forecasts in US$ by End-Use for the Period 2020-2027 |
| German Leukapheresis Market in Retrospect in US$ by End-Use: 2012-2019 |
| Leukapheresis Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027 |
| ITALY |
| Italian Leukapheresis Market Growth Prospects in US$ by Product for the Period 2020-2027 |
| Leukapheresis Historic Market Analysis in Italy in US$ by Product: 2012-2019 |
| Italian Leukapheresis Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Demand for Leukapheresis in US$ by Application: 2020 to 2027 |
| Leukapheresis Market Review in Italy in US$ by Application: 2012-2019 |
| Italian Leukapheresis Market Share Breakdown by Application: 2012 VS 2020 VS 2027 |
| Italian Demand for Leukapheresis in US$ by End-Use: 2020 to 2027 |
| Leukapheresis Market Review in Italy in US$ by End-Use: 2012-2019 |
| Italian Leukapheresis Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Leukapheresis: Annual Sales Estimates and Projections in US$ by Product for the Period 2020-2027 |
| Leukapheresis Market in the United Kingdom: Historic Sales Analysis in US$ by Product for the Period 2012-2019 |
| United Kingdom Leukapheresis Market Share Analysis by Product: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Leukapheresis in US$ by Application: 2020 to 2027 |
| United Kingdom Leukapheresis Market in US$ by Application: 2012-2019 |
| Leukapheresis Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Leukapheresis in US$ by End-Use: 2020 to 2027 |
| United Kingdom Leukapheresis Market in US$ by End-Use: 2012-2019 |
| Leukapheresis Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Leukapheresis Market Estimates and Forecasts in US$ by Product: 2020-2027 |
| Leukapheresis Market in Rest of Europe in US$ by Product: A Historic Review for the Period 2012-2019 |
| Rest of Europe Leukapheresis Market Share Breakdown by Product: 2012 VS 2020 VS 2027 |
| Rest of Europe Leukapheresis Addressable Market Opportunity in US$ by Application: 2020-2027 |
| Leukapheresis Market in Rest of Europe: Summarization of Historic Demand in US$ by Application for the Period 2012-2019 |
| Rest of Europe Leukapheresis Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Rest of Europe Leukapheresis Addressable Market Opportunity in US$ by End-Use: 2020-2027 |
| Leukapheresis Market in Rest of Europe: Summarization of Historic Demand in US$ by End-Use for the Period 2012-2019 |
| Rest of Europe Leukapheresis Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Leukapheresis Market in Asia-Pacific by Product: Estimates and Projections in US$ for the Period 2020-2027 |
| Asia-Pacific Leukapheresis Historic Market Scenario in US$ by Product: 2012-2019 |
| Asia-Pacific Leukapheresis Market Share Analysis by Product: 2012 VS 2020 VS 2027 |
| Leukapheresis Quantitative Demand Analysis in Asia-Pacific in US$ by Application: 2020-2027 |
| Asia-Pacific Leukapheresis Historic Market Review in US$ by Application: 2012-2019 |
| Asia-Pacific Leukapheresis Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 |
| Leukapheresis Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use: 2020-2027 |
| Asia-Pacific Leukapheresis Historic Market Review in US$ by End-Use: 2012-2019 |
| Asia-Pacific Leukapheresis Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| REST OF WORLD |
| Rest of World Leukapheresis Market Estimates and Forecasts in US$ by Product: 2020 to 2027 |
| Rest of World Leukapheresis Historic Market Review by Product in US$: 2012-2019 |
| Leukapheresis Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027 |
| Rest of World Leukapheresis Market Quantitative Demand Analysis in US$ by Application: 2020 to 2027 |
| Leukapheresis Market in Rest of World: Summarization of Historic Demand Patterns in US$ by Application for 2012-2019 |
| Rest of World Leukapheresis Market Share Analysis by Application: 2012 VS 2020 VS 2027 |
| Rest of World Leukapheresis Market Quantitative Demand Analysis in US$ by End-Use: 2020 to 2027 |
| Leukapheresis Market in Rest of World: Summarization of Historic Demand Patterns in US$ by End-Use for 2012-2019 |
| Rest of World Leukapheresis Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 8 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com